Primary Site >> Colorectal Cancer

Gene >> CYP3A4

Journal: Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4001-5.
Title: P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans.
Author: Schuetz, E G|Schinkel, A H|Relling, M V|Schuetz, J D
PMID: 8633005
Journal: Mol Pharmacol. 1996 Feb;49(2):311-8.
Title: Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.
Author: Schuetz, E G|Beck, W T|Schuetz, J D
PMID: 8632764
Journal: Mol Pharmacol. 1997 May;51(5):741-54.
Title: Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3.
Author: Schmiedlin-Ren, P|Thummel, K E|Fisher, J M|Paine, M F|Lown, K S|Watkins, P B
PMID: 9145912
Journal: Mutat Res. 1997 May 12;376(1-2):153-60.
Title: The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies.
Author: Windmill, K F|McKinnon, R A|Zhu, X|Gaedigk, A|Grant, D M|McManus, M E
PMID: 9202751
Journal: Cancer Res. 1998 Feb 1;58(3):468-72.
Title: Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions.
Author: Haaz, M C|Rivory, L|Riche, C|Vernillet, L|Robert, J
PMID: 9458091
Journal: Drug Metab Dispos. 1998 Aug;26(8):769-74.
Title: Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes.
Author: Haaz, M C|Riche, C|Rivory, L P|Robert, J
PMID: 9698291
Journal: Biochem Pharmacol. 1999 Apr 15;57(8):951-4.
Title: Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy.
Author: Elkahwaji, J|Robin, M A|Berson, A|Tinel, M|Letteron, P|Labbe, G|Beaune, P|Elias, D|Rougier, P|Escudier, B|Duvillard, P|Pessayre, D
PMID: 10086330
Journal: Biol Pharm Bull. 2000 Jul;23(7):810-4.
Title: Sulfotransferases in a human colon carcinoma cell line, Caco-2.
Author: Satoh, T|Matsui, M|Tamura, H
PMID: 10919357
Journal: Ann N Y Acad Sci. 2000;922:260-73.
Title: DX-8951f: summary of phase I clinical trials.
Author: De Jager, R|Cheverton, P|Tamanoi, K|Coyle, J|Ducharme, M|Sakamoto, N|Satomi, M|Suzuki, M
PMID: 11193901
Journal: Free Radic Res. 2000 Sep;33(3):279-85.
Title: Inhibitory effect of nitric oxide on the induction of cytochrome P450 3A4 mRNA by 1,25-dihydroxyvitamin D3 in Caco-2 cells.
Author: Hara, H|Mitani, N|Adachi, T
PMID: 10993481
Journal: Cancer Chemother Pharmacol. 2000;45(4):298-304.
Title: N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
Author: Brandes, L J|Queen, G M|LaBella, F S
PMID: 10755318
Journal: J Clin Pharmacol. 2000 Jan;40(1):91-8.
Title: Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion.
Author: Boyd, R A|Stern, R H|Stewart, B H|Wu, X|Reyner, E L|Zegarac, E A|Randinitis, E J|Whitfield, L
PMID: 10631627
Journal: J Biol Chem. 2001 May 4;276(18):14581-7. Epub 2001 Jan 31.
Title: Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin.
Author: Geick, A|Eichelbaum, M|Burk, O
PMID: 11297522
Journal: J Pharm Sci. 2001 Jun;90(6):722-31.
Title: Hepatic extraction, metabolism, and biliary excretion of irinotecan in the isolated perfused rat liver.
Author: Farabos, C|Haaz, M C|Gires, P|Robert, J
PMID: 11357175
Journal: Pharm Res. 2001 Aug;18(8):1102-9.
Title: Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
Author: Cummins, C L|Mangravite, L M|Benet, L Z
PMID: 11587480
Journal: Br J Cancer. 2002 Sep 9;87(6):681-6.
Title: Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.
Author: Martinez, C|Garcia-Martin, E|Pizarro, R M|Garcia-Gamito, F J|Agundez, J A G
PMID: 12237780
Journal: Biochem Biophys Res Commun. 2002 Dec 20;299(5):730-8.
Title: Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements.
Author: Thompson, Paul D|Jurutka, Peter W|Whitfield, G Kerr|Myskowski, Sandy M|Eichhorst, Kristina R|Dominguez, Carlos Encinas|Haussler, Carol A|Haussler, Mark R
PMID: 12470639
Journal: Biochem Biophys Res Commun. 2002 Nov 15;298(5):687-92.
Title: Modulation of CYP3A4 expression by ceramide in human colon carcinoma HT-29 cells.
Author: Chun, Young-Jin|Lee, Sunghee|Yang, Soon Ae|Park, Sungsik|Kim, Mie Young
PMID: 12419308
Journal: J Cell Biochem. 2002;87(2):147-59.
Title: Ketoconazole potentiates terfenadine-induced apoptosis in human Hep G2 cells through inhibition of cytochrome p450 3A4 activity.
Author: Wang, Ying-Jan|Yu, Cheng-Fei|Chen, Li-Ching|Chen, Chien-Ho|Lin, Jen-Kun|Liang, Yu-Chih|Lin, Chien-Huang|Lin, Shyr-Yi|Chen, Chin-Fa|Ho, Yuan-Soon
PMID: 12244568
Journal: J Clin Oncol. 2002 Jul 15;20(14):3122-9.
Title: Modulation of irinotecan metabolism by ketoconazole.
Author: Kehrer, Diederik F S|Mathijssen, Ron H J|Verweij, Jaap|de Bruijn, Peter|Sparreboom, Alex
PMID: 12118026
Journal: Science. 2002 May 17;296(5571):1313-6.
Title: Vitamin D receptor as an intestinal bile acid sensor.
Author: Makishima, Makoto|Lu, Timothy T|Xie, Wen|Whitfield, G Kerr|Domoto, Hideharu|Evans, Ronald M|Haussler, Mark R|Mangelsdorf, David J
PMID: 12016314
Journal: J Pharm Pharmacol. 2003 Jan;55(1):59-66.
Title: Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines.
Author: Pfrunder, Arabelle|Gutmann, Heike|Beglinger, Christoph|Drewe, Jurgen
PMID: 12625868
Journal: Pharm Res. 2003 Feb;20(2):324-7.
Title: Gene expression profiles of ABC transporters and cytochrome P450 3A in Caco-2 and human colorectal cancer cell lines.
Author: Nakumura, Tsutomu|Sakaeda, Toshiyuki|Ohmoto, Nobuko|Moriya, Yuka|Komoto, Chiho|Shirakawa, Toshiro|Gotoh, Akinobu|Matsuo, Masafumi|Okmura, Katsuhiko
PMID: 12636175
Journal: Life Sci. 2003 May 30;73(2):141-9.
Title: Induction of CYP3A4 by 1alpha,25-dyhydroxyvitamin D3 in HepG2 cells.
Author: Elizondo, Guillermo|Medina-Diaz, Irma M
PMID: 12738030
Journal: Life Sci. 2003 Nov 21;74(1):99-108.
Title: Role of c-Myc in nitric oxide-mediated suppression of cytochrome P450 3A4.
Author: Watabe, Masahiko|Isogai, Yumiko|Numazawa, Satoshi|Yoshida, Takemi
PMID: 14575816
Journal: Toxicol Lett. 2003 Dec 15;146(1):75-81.
Title: Activation of Fas receptor modulates cytochrome P450 3A4 expression in human colon carcinoma cells.
Author: Chun, Young-Jin|Park, Sungsik|Yang, Soon Ae
PMID: 14615069
Journal: Am J Ther. 2004 Mar-Apr;11(2):114-23.
Title: A Mathematical simulation to explain the coordinated functions of efflux and metabolism limiting the transport of anti-HIV agents across Caco-2 cells.
Author: Patel, Jignesh|Hussain, Azher|Pal, Dhahanjay|Mitra, Ashim K
PMID: 14999363
Journal: Drug Metab Dispos. 2004 Jul;32(7):685-8.
Title: C-jun N-terminal kinase modulates 1,25-dihydroxyvitamin D3-induced cytochrome P450 3A4 gene expression.
Author: Yasunami, Yoko|Hara, Hirokazu|Iwamura, Tatsunori|Kataoka, Tadashi|Adachi, Tetsuo
PMID: 15205382
Journal: Drug Metab Dispos. 2004 Aug;32(8):779-82.
Title: Levothyroxine up-regulates P-glycoprotein independent of the pregnane X receptor.
Author: Mitin, Tim|Von Moltke, Lisa L|Court, Michael H|Greenblatt, David J
PMID: 15258100
Journal: Biochem Biophys Res Commun. 2004 Sep 3;321(4):909-15.
Title: Loss of CYP3A7 gene induction by 1,25-dihydroxyvitamin D3 is caused by less binding of VDR to the proximal ER6 in CYP3A7 gene.
Author: Hara, Hirokazu|Yasunami, Yoko|Adachi, Tetsuo
PMID: 15358113
Journal: J Natl Cancer Inst. 2004 Nov 3;96(21):1585-92.
Title: Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes.
Author: Mathijssen, Ron H J|de Jong, Floris A|van Schaik, Ron H N|Lepper, Erin R|Friberg, Lena E|Rietveld, Trinet|de Bruijn, Peter|Graveland, Wilfried J|Figg, William D|Verweij, Jaap|Sparreboom, Alex
PMID: 15523087
Journal: Biochem Biophys Res Commun. 2005 Aug 19;334(1):9-15.
Title: Promoter-, cell-, and ligand-specific transactivation responses of the VDRB1 isoform.
Author: Esteban, Luis M|Fong, Colette|Amr, Deama|Cock, Terrie-Anne|Allison, Susan J|Flanagan, Judith L|Liddle, Chris|Eisman, John A|Gardiner, Edith M
PMID: 15992766
Journal: Pharmacogenet Genomics. 2005 Aug;15(8):535-46.
Title: A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.
Author: Landi, Stefano|Gemignani, Federica|Moreno, Victor|Gioia-Patricola, Lydie|Chabrier, Amelie|Guino, Elisabeth|Navarro, Matilde|de Oca, Javier|Capella, Gabriel|Canzian, Federico
PMID: 16006997
Journal: Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 2005;(123):68-72.
Title: [Network for the collection and distribution of Japanese liver tissues resected surgically for drug development and research use].
Author: Sunouchi, Momoko|Sakemi, Kazue|Kubota, Kei-ichi|Kita, Junji|Kamikawa, Yuichiro|Uchida, Kohsuke|Miura, Shin-ichi|Shigehara, Eiji|Fujioka, Hiroyuki|Ohno, Yasuo
PMID: 16541756
Journal: Expert Opin Drug Metab Toxicol. 2005 Aug;1(2):175-85.
Title: Caco-2 cell permeability assays to measure drug absorption.
Author: van Breemen, Richard B|Li, Yongmei
PMID: 16922635
Journal: Cancer Chemother Pharmacol. 2005 Sep;56(3):248-54. Epub 2005 Apr 27.
Title: P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing.
Author: Gustafson, Daniel L|Long, Michael E|Bradshaw, Erica L|Merz, Andrea L|Kerzic, Patrick J
PMID: 15856231
Journal: Am J Pharmacogenomics. 2005;5(1):21-33.
Title: Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications.
Author: Lentz, Frederike|Tran, Agnes|Rey, Elisabeth|Pons, Gerard|Treluyer, Jean-Marc
PMID: 15727486
Journal: Br J Cancer. 2005 Jan 31;92(2):259-64.
Title: Unfavourable expression of pharmacologic markers in mucinous colorectal cancer.
Author: Glasgow, S C|Yu, J|Carvalho, L P|Shannon, W D|Fleshman, J W|McLeod, H L
PMID: 15655543
Journal: J Cell Biochem. 2005 Apr 1;94(5):917-43.
Title: Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.
Author: Jurutka, Peter W|Thompson, Paul D|Whitfield, G Kerr|Eichhorst, Kristina R|Hall, Neal|Dominguez, Carlos Encinas|Hsieh, Jui-Cheng|Haussler, Carol A|Haussler, Mark R
PMID: 15578590
Journal: Clin Cancer Res. 2005 May 15;11(10):3758-65.
Title: Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.
Author: Kumarakulasingham, Meera|Rooney, Patrick H|Dundas, Sinclair R|Telfer, Colin|Melvin, William T|Curran, Stephanie|Murray, Graeme I
PMID: 15897573
Journal: Curr Clin Pharmacol. 2006 Sep;1(3):311-23.
Title: Clinical pharmacokinetics of irinotecan-based chemotherapy in colorectal cancer patients.
Author: Di Paolo, Antonello|Bocci, Guido|Danesi, Romano|Del Tacca, Mario
PMID: 18666754
Journal: Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4426s-4431s.
Title: Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway.
Author: Dimitroulakos, Jim|Lorimer, Ian A|Goss, Glenwood
PMID: 16857822
Journal: Planta Med. 2006 Jun;72(8):685-90. Epub 2006 Jun 1.
Title: Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?
Author: Gutmann, Heike|Poller, Birk|Buter, Karin Berger|Pfrunder, Arabelle|Schaffner, Willi|Drewe, Jurgen
PMID: 16755466
Journal: Pharmacogenomics. 2006 Jun;7(4):575-85.
Title: Acquired resistance to the anticancer drug paclitaxel is associated with induction of cytochrome P450 2C8.
Author: Garcia-Martin, Elena|Pizarro, Rosa M|Martinez, Carmen|Gutierrez-Martin, Yolanda|Perez, Gabriela|Jover, Ramiro|Agundez, Jose Ag
PMID: 16753005
Journal: Clin Pharmacol Ther. 2006 May;79(5):449-60. Epub 2006 Apr 11.
Title: Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans.
Author: Becquemont, Laurent|Glaeser, Hartmut|Drescher, Siegfried|Hitzl, Monika|Simon, Nicolas|Murdter, Thomas E|Heinkele, Georg|Hofmann, Ute|Schaefer, Christian|Burk, Oliver|Verstuyft, Celine|Eichelbaum, Michel|Fromm, Martin F
PMID: 16678547
Journal: Phytother Res. 2007 Mar;21(3):239-44.
Title: Effects of herbal medicinal products and food supplements on induction of CYP1A2, CYP3A4 and MDR1 in the human colon carcinoma cell line LS180.
Author: Brandin, Helena|Viitanen, Eila|Myrberg, Olle|Arvidsson, Ann-Kristin
PMID: 17163579
Journal: Inflamm Bowel Dis. 2007 Jun;13(6):710-20.
Title: Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels.
Author: Blokzijl, Hans|Vander Borght, Sara|Bok, Lisette I H|Libbrecht, Louis|Geuken, Mariska|van den Heuvel, Fiona A J|Dijkstra, Gerard|Roskams, Tania A D|Moshage, Han|Jansen, Peter L M|Faber, Klaas Nico
PMID: 17262809
Journal: Phytomedicine. 2007 Aug;14(7-8):498-507.
Title: In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato.
Author: Nair, Vipin D P|Foster, Brian C|Thor Arnason, J|Mills, Edward J|Kanfer, Isadore
PMID: 17336049
Journal: Eur J Clin Pharmacol. 2007 Jun;63(6):547-54. Epub 2007 Apr 3.
Title: Identification of NR1I2 genetic variation using resequencing.
Author: King, Cristi R|Xiao, Ming|Yu, Jinsheng|Minton, Matthew R|Addleman, Nicholas J|Van Booven, Derek J|Kwok, Pui-Yan|McLeod, Howard L|Marsh, Sharon
PMID: 17404718
Journal: BMC Cancer. 2007 Jul 2;7:118.
Title: Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.
Author: Gervasini, Guillermo|Garcia-Martin, Elena|Ladero, Jose M|Pizarro, Rosa|Sastre, Javier|Martinez, Carmen|Garcia, Monserrat|Diaz-Rubio, Manuel|Agundez, Jose A G
PMID: 17605821
Journal: BMC Cancer. 2007 Jul 5;7:123.
Title: Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.
Author: Bethke, Lara|Webb, Emily|Sellick, Gabrielle|Rudd, Matthew|Penegar, Stephen|Withey, Laura|Qureshi, Mobshra|Houlston, Richard
PMID: 17615053
Journal: Cancer Res. 2007 Jul 15;67(14):6995-7002.
Title: Tamoxifen forms DNA adducts in human colon after administration of a single [14C]-labeled therapeutic dose.
Author: Brown, Karen|Tompkins, Elaine M|Boocock, David J|Martin, Elizabeth A|Farmer, Peter B|Turteltaub, Kenneth W|Ubick, Esther|Hemingway, David|Horner-Glister, Emma|White, Ian N H
PMID: 17638912
Journal: Clin Ther. 2008 Aug;30(8):1385-407.
Title: Drug interactions between chemotherapeutic regimens and antiepileptics.
Author: Yap, Kevin Yi-Lwern|Chui, Wai Keung|Chan, Alexandre
PMID: 18803983
Journal: Br J Cancer. 2008 Oct 21;99(8):1239-45.
Title: Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients.
Author: Rouits, E|Charasson, V|Petain, A|Boisdron-Celle, M|Delord, J-P|Fonck, M|Laurand, A|Poirier, A-L|Morel, A|Chatelut, E|Robert, J|Gamelin, E
PMID: 18797458
Journal: Drug Metab Dispos. 2008 May;36(5):946-54.
Title: Role of human pregnane X receptor in tamoxifen- and 4-hydroxytamoxifen-mediated CYP3A4 induction in primary human hepatocytes and LS174T cells.
Author: Sane, Rucha S|Buckley, Donna J|Buckley, Arthur R|Nallani, Srikanth C|Desai, Pankaj B
PMID: 18299335
Journal: Invest New Drugs. 2008 Feb;26(1):25-34.
Title: Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity.
Author: Rajendran, Praveen|Jaggi, Manu|Singh, Manoj K|Mukherjee, Rama|Burman, Anand C
PMID: 17851638
Journal: Drug Metab Dispos. 2008 Jul;36(7):1283-90.
Title: Effects of spice constituents on P-glycoprotein-mediated transport and CYP3A4-mediated metabolism in vitro.
Author: Zhang, Wenxia|Lim, Lee-Yong
PMID: 18385293
Journal: Eur J Pharm Sci. 2009 Mar 2;36(4-5):565-71.
Title: PXR-mediated induction of human CYP3A4 and mouse Cyp3a11 by the glucocorticoid budesonide.
Author: Zimmermann, Christian|van Waterschoot, Robert A B|Harmsen, Stefan|Maier, Angelika|Gutmann, Heike|Schinkel, Alfred H
PMID: 19138736
Journal: J Nutr Biochem. 2010 Dec;21(12):1153-61.
Title: Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.
Author: Bartik, Leonid|Whitfield, G Kerr|Kaczmarska, Magdalena|Lowmiller, Christine L|Moffet, Eric W|Furmick, Julie K|Hernandez, Zachary|Haussler, Carol A|Haussler, Mark R|Jurutka, Peter W
PMID: 20153625
Journal: Endocr Relat Cancer. 2011 Mar 9;18(2):265-76.
Title: Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
Author: Sainz, J|Rudolph, A|Hein, R|Hoffmeister, M|Buch, S|von Schonfels, W|Hampe, J|Schafmayer, C|Volzke, H|Frank, B|Brenner, H|Forsti, A|Hemminki, K|Chang-Claude, J
PMID: 21317201
Journal: BMC Cancer. 2011 Feb 22;11:81.
Title: Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells.
Author: Habano, Wataru|Gamo, Toshie|Terashima, Jun|Sugai, Tamotsu|Otsuka, Koki|Wakabayashi, Go|Ozawa, Shogo
PMID: 21342487
Journal: Endocr Relat Cancer. 2011 Jun 8;18(3):371-84.
Title: Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
Author: Rudolph, Anja|Sainz, Juan|Hein, Rebecca|Hoffmeister, Michael|Frank, Bernd|Forsti, Asta|Brenner, Hermann|Hemminki, Kari|Chang-Claude, Jenny
PMID: 21490239
Journal: Mol Cancer. 2011 Jul 6;10:80.
Title: Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells.
Author: Basseville, Agnes|Preisser, Laurence|de Carne Trecesson, Sophie|Boisdron-Celle, Michele|Gamelin, Erick|Coqueret, Olivier|Morel, Alain
PMID: 21733184
Journal: Postepy Hig Med Dosw (Online). 2011 Jun 17;65:367-76.
Title: [Expression systems of cytochrome P450 proteins in studies of drug metabolism in vitro].
Author: Pawlowska, Monika|Augustin, Ewa
PMID: 21734321
Journal: Cancers (Basel). 2011 Mar 22;3(1):1467-79.
Title: Overexpression of CYP3A4 in a COLO 205 Colon Cancer Stem Cell Model in vitro.
Author: Olszewski, Ulrike|Liedauer, Richard|Ausch, Christoph|Thalhammer, Theresia|Hamilton, Gerhard
PMID: 24212669
Journal: Acta Medica (Hradec Kralove). 2012;55(4):153-9.
Title: Predictors of irinotecan toxicity and efficacy in treatment of metastatic colorectal cancer.
Author: Paulik, Adam|Grim, Jiri|Filip, Stanislav
PMID: 23631285
Journal: Org Med Chem Lett. 2012 Jun 11;2(1):21.
Title: Cytotoxic and potent CYP1 inhibitors from the marine algae Cymopolia barbata.
Author: Badal, Simone|Gallimore, Winklet|Huang, George|Tzeng, Tzuen-Rong Jeremy|Delgoda, Rupika
PMID: 22686946
Journal: Curr Drug Targets. 2013 Jun;14(7):777-97.
Title: Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.
Author: Swami, Umang|Goel, Sanjay|Mani, Sridhar
PMID: 23597015
Journal: Clin Cancer Res. 2013 Sep 1;19(17):4832-42.
Title: Phase I safety, pharmacokinetic and pharmacodynamic evaluation of the vascular disrupting agent ombrabulin (AVE8062) in patients with advanced solid tumors.
Author: Sessa, Cristiana|Lorusso, Patricia|Tolcher, Anthony|Farace, Francoise|Lassau, Nathalie|Delmonte, Angelo|Braghetti, Antonio|Bahleda, Rastislav|Cohen, Patrick|Hospitel, Marie|Veyrat-Follet, Christine|Soria, Jean-Charles
PMID: 23833302
Journal: Cancer Causes Control. 2014 May;25(5):561-70.
Title: Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans.
Author: Pibiri, Fabio|Kittles, Rick A|Sandler, Robert S|Keku, Temitope O|Kupfer, Sonia S|Xicola, Rosa M|Llor, Xavier|Ellis, Nathan A
PMID: 24562971
Journal: Cell Biosci. 2014 Apr 1;4(1):17.
Title: Tissue-specific regulation of pregnane X receptor in cancer development and therapy.
Author: Robbins, Delira|Chen, Taosheng
PMID: 24690092
Journal: Cell Physiol Biochem. 2014;33(5):1400-10.
Title: Short-term effects of oral administration of Pistacia lentiscus oil on tissue-specific toxicity and drug metabolizing enzymes in mice.
Author: Attoub, Samir|Karam, Sherif M|Nemmar, Abderrahim|Arafat, Kholoud|John, Annie|Al-Dhaheri, Wafa|Al Sultan, Mahmood Ahmed|Raza, Haider
PMID: 24853661
Journal: Oncol Lett. 2014 Dec;8(6):2407-2416.
Title: Effects of co-treatment with sulforaphane and autophagy modulators on uridine 5'-diphospho-glucuronosyltransferase 1A isoforms and cytochrome P450 3A4 expression in Caco-2 human colon cancer cells.
Author: Wang, Min|Zhu, Jing-Yu|Chen, Shuo|Qing, Ying|Wu, Dong|Lin, Ying-Min|Luo, Ji-Zhuang|Han, Wei|Li, Yan-Qing
PMID: 25364403
Journal: Biomed Pharmacother. 2016 Jul;81:38-47.
Title: Drug membrane transporters and CYP3A4 are affected by hypericin, hyperforin or aristoforin in colon adenocarcinoma cells.
Author: Semelakova, M|Jendzelovsky, R|Fedorocko, P
PMID: 27261575
Journal: Mol Cancer Ther. 2016 Sep;15(9):2086-95.
Title: Vitamin D Enhances the Efficacy of Irinotecan through miR-627-Mediated Inhibition of Intratumoral Drug Metabolism.
Author: Sun, Meiyan|Zhang, Qunshu|Yang, Xiaoyu|Qian, Steven Y|Guo, Bin
PMID: 27458137
Journal: Cancer Chemother Pharmacol. 2017 Sep;80(3):527-533.
Title: Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients.
Author: Makihara, Katsuya|Nakamura, Sayaka|Miyagi, Kazuyo|Ueno, Hiroyuki|Nakata, Izumi
PMID: 28711984
Journal: Drug Des Devel Ther. 2017 Sep 5;11:2621-2629.
Title: Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations.
Author: Rapoport, Bernardo Leon|Aapro, Matti|Chasen, Martin R|Jordan, Karin|Navari, Rudolph M|Schnadig, Ian|Schwartzberg, Lee
PMID: 28919712
Journal: Pharmacol Res. 2018 Jul;133:9-20.
Title: The burgeoning role of cytochrome P450-mediated vitamin D metabolites against colorectal cancer.
Author: Wang, Peili|Qin, Xuan|Liu, Mingyao|Wang, Xin
PMID: 29719203